期刊文献+

不同期别宫颈癌术前介入治疗的效果 被引量:2

Effect of interventional therapy before operation for cervical carcinoma in different stage
下载PDF
导出
摘要 目的探讨不同期别宫颈癌术前介入治疗的效果。方法对30例Ⅰb2-Ⅲb期宫颈癌患者,采用Seldinger技术,行超选择性子宫动脉灌注化疗,加行子宫动脉栓塞治疗。化疗药物采用博莱霉素、顺铂及异环磷酰胺三药联合。栓塞剂采用明胶海绵颗粒。3周后进行妇科检查,判断动脉化疗及栓塞的治疗效果,决定下一步治疗方案。对手术治疗者再根据术中情况及术后病理结果进一步评价介入治疗的效果。结果介入治疗总有效率93.3%(28/30),临床完全缓解率13.3%(4/30)。其中,Ⅰb2-Ⅱb期有效率为100%(27/27),Ⅲb期有效率为33.3%(1/3)。有效的患者主要表现为宫颈局部病灶缩小明显。介入治疗后手术率为86.7%(26/30),病理完全缓解率6.7%(2/30)。结论超选择性子宫动脉灌注化疗加栓塞,对Ⅰb2-Ⅱb期宫颈癌患者有较好的疗效,能有效地缩小肿瘤体积,有利于手术进行,故在临床上可根据患者的情况选择性应用。 Objective To investigate effect of interventional therapy before surgical treatment of cervical carcinoma in different stage. Methods Thirty patients with stage Ⅰb2-Ⅲb cervical carcinoma were treated by super selective uterine artery chemotherapy and uterine artery embolization followed by chemotherapy. Cisplatin, bleomycin and ifosfomide were the drugs in the combination chemotherapy regimen. Pelvic examination was performed 3 weeks late to estimate the effect of the therapy and to determine the followed treatment measures. The effect of chemotherapy and embolization was assessed again for patients undergoing surgery after operation. Results The overall response rate of interventional therapy for cervical cancer was 93.3% (28/30) ,clinical complete response rate was13.3% (4/30). The response rates were 100% in 27 stage Ⅰb2-Ⅱb and 33.3% in stage Ⅲb(1/3) patients. The main sign for the response patients is cervical tumor decreasmy. The successful rate of operation was 86.7% (26/30) after transcatheter therapy and 6.7% pathologic complete response rate was achieved. Condusion Transcatheter super selective uterine artery chemotherapy and embolization is effective in the treatment of stage Ⅰb2-Ⅱb cervical carcinoma, it should be used for some selective patients before surgery.
出处 《中原医刊》 2007年第12期9-11,共3页 Central Plains Medical Journal
关键词 宫颈肿瘤 子宫动脉化疗 子宫动脉栓塞 Cervical neoplasms Uterine artery chemotherapy Uterine artery embolization
  • 相关文献

参考文献9

二级参考文献15

  • 1Park SY, Kim BG, Kim JH, et al. Phase Ⅰ/Ⅱ study of neoadjuvant intraarterial chemotherapy with miromycin-C, vincristine and cisplatin in patients with stage Ⅱb bulky cervical carcinoma. Cancer, 1995, 76:814-823. 被引量:1
  • 2Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64. 被引量:1
  • 3Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer.Ann Surg Oncol,1998,5:539-543. 被引量:1
  • 4Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰ B and Ⅱ A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24. 被引量:1
  • 5Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103. 被引量:1
  • 6Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992. 被引量:1
  • 7Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93. 被引量:1
  • 8Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage ⅠB, ⅡA, and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000, 77:305-309. 被引量:1
  • 9Yamada T, Ohsugi F, Irie T,et al. Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of a vascular access device. Cardiovasc Intervent Radiol,1996,19:139-145. 被引量:1
  • 10Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol,2001,83:263-267. 被引量:1

共引文献301

同被引文献42

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部